Abstract
COVID-19 (SARS-CoV-2) is a pandemic disease characterized with respiratory infection and caused by coronavirus and spread worldwide after an outbreak began in Wuhan, China, in December 2019. This review covers general information on COVID 19 and the treatment options available through different trials. Specifically, we discussed blood safety during COVID-19 pandemic and the benefit using of convalescent plasma treatment. Blood donor, staff and patient safety are essential to reduce the risk of Corona virus (COVID 19) infection. There are many steps taken by countries worldwide to fight against this virus and blood safety is one of the major steps towards reaching their goal. The health of people has always the priority therefore, all blood donation centres and institutions should have high precautions, accuracy and maintenance to minimize the transmission of virus through blood transfusion.